VanEck Pharma

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Trend Stats

1-Month Return -4.08%
3-Month Return +6.67%
12-Month Return +14.36%
Volatility Score 1.6
RSI 40.3
ST Trend Down
LT Trend Up

Short-Term Trend

Down

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

VanEck Pharma
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
LLY Eli Lilly & Co $878B +14.73% -1.81% -6.26% 3.7 Down Up
JNJ Johnson&Johnson $577B +48.24% +19.68% +0.70% 1.8 Up Up
ABBV AbbVie $411B +10.98% +2.60% +2.99% 2.5 Neutral Up
NVS Novartis Sp ADR $307B +43.70% +21.16% +2.37% 2.0 Up Up
MRK Merck $287B +26.93% +17.11% -5.04% 2.7 Neutral Up
PFE Pfizer $151B +8.54% +5.66% -0.62% 2.2 Up Up
NVO Nordisk Sp ADR-B $132B -54.49% -19.39% -19.02% 5.0 Down Down
BMY Bristol-MyersSqu $124B +3.68% +16.98% -2.74% 2.5 Up Up
MCK Mckesson $114B +43.26% +13.78% -3.02% 3.4 Up Up
GSK GSK Sp ADR $111B +41.62% +13.51% -8.77% 2.3 Neutral Up
SNY SANOFI SP ADR $109B -21.50% -10.05% -6.86% 2.3 Down Down
COR Cencora $70B +41.81% +5.72% -0.05% 3.1 Neutral Up
TAK TAKEDA PHARM SP ADR $56B +23.30% +26.09% -0.06% 1.7 Up Up
ZTS Zoetis-A $52B -27.69% +2.78% -4.70% 3.3 Down Down
HLN Haleon Sp ADR $46B +0.19% +7.98% -6.38% 2.4 Down Up
TEVA TEVAPHARMIND SP ADR $37B +102.15% +9.10% -10.49% 3.1 Down Up
VTRS Viatris $17B +54.19% +29.55% -2.88% 3.9 Neutral Up
ELAN ELANC ANIML HLTH $12B +109.69% +6.67% -7.30% 4.2 Down Up
JAZZ Jazz Pharmaceuti $11B +31.12% +7.25% +9.98% 3.1 Up Up
AXSM Axsome Therapeut $8.3B +32.87% +8.79% -11.08% 3.5 Down Up
CORT Corcept Therapeu $3.6B -38.86% -60.66% -17.05% 6.8 Down Down
BHC BAUSCH HEALTH $2.1B -24.76% -22.37% -8.50% 5.1 Down Down
OGN Organon $1.7B -57.10% -7.90% -19.90% 5.9 Down Down
PRGO Perrigo $1.5B -58.71% -18.45% -25.13% 5.4 Down Down